{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:55:29Z","timestamp":1775843729380,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"DOI":"10.7759\/cureus.59520","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T14:57:23Z","timestamp":1714661843000},"source":"Crossref","is-referenced-by-count":2,"title":["Incidental Intense Fibroblast Activation Protein Inhibitor (FAPI) Uptake in Bilateral Gluteal Myositis Ossificans: A Case Report"],"prefix":"10.7759","author":[{"given":"Rakan","family":"Al-Rashdan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Ruzzeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabeela","family":"Al-Hajaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ula","family":"Al-Rasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akram","family":"Al-Ibraheem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154514","article-title":"Emerging role of FAPI PET imaging for the assessment of benign bone and joint diseases","volume":"11","author":"Dondi F","year":"2022","unstructured":"Dondi F, Albano D, Treglia G, Bertagna F. Emerging role of FAPI PET imaging for the assessment of benign bone and joint diseases. J Clin Med. 2022, 11:4514. 10.3390\/jcm11154514","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.945602","article-title":"Positron emission tomography imaging of lung cancer: an overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose","volume":"9","author":"Zhu J","year":"2022","unstructured":"Zhu J, Pan F, Cai H, et al.. Positron emission tomography imaging of lung cancer: an overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose. Front Med (Lausanne). 2022, 9:945602. 10.3389\/fmed.2022.945602","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.245084","article-title":"FAPI-74 PET\/CT using either 18F-AlF or Cold-Kit 68Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients","volume":"62","author":"Giesel FL","year":"2021","unstructured":"Giesel FL, Adeberg S, Syed M, et al.. FAPI-74 PET\/CT using either 18F-AlF or Cold-Kit 68Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients. J Nucl Med. 2021, 62:201-7. 10.2967\/jnumed.120.245084","journal-title":"J Nucl Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil C","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, et al.. 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019, 60:801-5. 10.2967\/jnumed.119.227967","journal-title":"J Nucl Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1101\/gad.279737.116","article-title":"Carcinoma-associated fibroblasts: orchestrating the composition of malignancy","volume":"30","author":"Gascard P","year":"2016","unstructured":"Gascard P, Tlsty TD. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev. 2016, 30:1002-19. 10.1101\/gad.279737.116","journal-title":"Genes Dev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20220463","article-title":"Non-oncologic incidental uptake on FAPI PET\/CT imaging","volume":"96","author":"Hotta M","year":"2023","unstructured":"Hotta M, Rieger AC, Jafarvand MG, Menon N, Farolfi A, Benz MR, Calais J. Non-oncologic incidental uptake on FAPI PET\/CT imaging. Br J Radiol. 2023, 96:20220463. 10.1259\/bjr.20220463","journal-title":"Br J Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194946","article-title":"FAP and FAPI-PET\/CT in malignant and non-malignant diseases: a perfect symbiosis?","volume":"13","author":"Dendl K","year":"2021","unstructured":"Dendl K, Koerber SA, Kratochwil C, et al.. FAP and FAPI-PET\/CT in malignant and non-malignant diseases: a perfect symbiosis?. Cancers (Basel). 2021, 13:4946. 10.3390\/cancers13194946","journal-title":"Cancers (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004802","article-title":"68 Ga-FAPI PET\/CT imaging : unveiling the hidden pitfalls","volume":"48","author":"Al-Ibraheem A","year":"2023","unstructured":"Al-Ibraheem A, Abdlkadir AS, Alalawi H, Badarneh M. 68 Ga-FAPI PET\/CT imaging : unveiling the hidden pitfalls. Clin Nucl Med. 2023, 48:965-6. 10.1097\/RLU.0000000000004802","journal-title":"Clin Nucl Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-024-00844-7","article-title":"Stent-induced [68Ga]Ga-FAPI diffuse expression in a patient with pancreatic cancer: navigating non-oncologic challenges","author":"Al-Ibraheem A","year":"2024","unstructured":"Al-Ibraheem A, Sweedat DA, Abdlkadir AS, Stanimirovi\u0107 D, Dadgar H. Stent-induced [68Ga]Ga-FAPI diffuse expression in a patient with pancreatic cancer: navigating non-oncologic challenges. Nucl Med Mol Imaging. 2024, 10.1007\/s13139-024-00844-7","journal-title":"Nucl Med Mol Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004652","article-title":"68 Ga-FAPI PET\/CT provides a clear picture of a Klatskin tumor that 18 F-FDG PET\/CT missed","volume":"48","author":"Al-Ibraheem A","year":"2023","unstructured":"Al-Ibraheem A, Al-Qasem S, El Khaldi M, Amarin R. 68 Ga-FAPI PET\/CT provides a clear picture of a Klatskin tumor that 18 F-FDG PET\/CT missed. Clin Nucl Med. 2023, 48:e313-5. 10.1097\/RLU.0000000000004652","journal-title":"Clin Nucl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06348-4","article-title":"[68Ga]Ga-DOTA-FAPI-04 PET\/CT depicts metastases from medullary thyroid cancer that [68Ga]Ga-DOTATOC\u00a0PET\/CT\u00a0missed","volume":"50","author":"Al-Ibraheem A","year":"2023","unstructured":"Al-Ibraheem A, Alyasjeen SF, Abdlkadir AS, Sheikha AA. [68Ga]Ga-DOTA-FAPI-04 PET\/CT depicts metastases from medullary thyroid cancer that [68Ga]Ga-DOTATOC\u00a0PET\/CT\u00a0missed. Eur J Nucl Med Mol Imaging. 2023, 50:4112-3. 10.1007\/s00259-023-06348-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56173","article-title":"Gallium-68-labeled fibroblast activation protein inhibitor as an alternative radiotracer to fluorine 18-fluorodeoxyglucose: a case report of rare pulmonary colloid adenocarcinoma diagnosed by PET\/CT","volume":"16","author":"Mansour A","year":"2024","unstructured":"Mansour A, Obeidat S, Al-Adhami D, Abu Hejleh T, Al-Ibraheem A. Gallium-68-labeled fibroblast activation protein inhibitor as an alternative radiotracer to fluorine 18-fluorodeoxyglucose: a case report of rare pulmonary colloid adenocarcinoma diagnosed by PET\/CT. Cureus. 2024, 16:e56173. 10.7759\/cureus.56173","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2021.03.005","article-title":"Myositis ossificans revisited - the largest reported case series","volume":"17","author":"Saad A","year":"2021","unstructured":"Saad A, Azzopardi C, Patel A, Davies AM, Botchu R. Myositis ossificans revisited - the largest reported case series. J Clin Orthop Trauma. 2021, 17:123-7. 10.1016\/j.jcot.2021.03.005","journal-title":"J Clin Orthop Trauma"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1249\/JSR.0000000000000515","article-title":"Myositis ossificans in sport: a review","volume":"17","author":"Devilbiss Z","year":"2018","unstructured":"Devilbiss Z, Hess M, Ho GW. Myositis ossificans in sport: a review. Curr Sports Med Rep. 2018, 17:290-5. 10.1249\/JSR.0000000000000515","journal-title":"Curr Sports Med Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-024-00638-z","article-title":"Investigating the diffuse pancreatic expression of [68Ga]Ga-DOTA-FAPI: location, timing, and molecular imaging approaches","volume":"23","author":"Al-Ibraheem A","year":"2024","unstructured":"Al-Ibraheem A, Badarneh M, Abdlkadir AS, Al-Qasem S, Ruzzeh S, Giammarile F. Investigating the diffuse pancreatic expression of [68Ga]Ga-DOTA-FAPI: location, timing, and molecular imaging approaches. Clin Transl Imaging. 2024, 23:1-5. 10.1007\/s40336-024-00638-z","journal-title":"Clin Transl Imaging"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-020-03521-w","article-title":"Traumatic myositis ossificans: multifocal lesions suggesting malignancy on FDG-PET\/CT-a case report","volume":"50","author":"Sasaki M","year":"2021","unstructured":"Sasaki M, Hotokezaka Y, Ideguchi R, Uetani M, Fujita S. Traumatic myositis ossificans: multifocal lesions suggesting malignancy on FDG-PET\/CT-a case report. Skeletal Radiol. 2021, 50:249-54. 10.1007\/s00256-020-03521-w","journal-title":"Skeletal Radiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2017.01.017","article-title":"Imaging in myositis ossificans: bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography\/computed tomography","volume":"14","author":"S\u00e1nchez Aguilar M","year":"2018","unstructured":"S\u00e1nchez Aguilar M, Garc\u00eda Jim\u00e9nez R, Borrego Dorado I. Imaging in myositis ossificans: bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography\/computed tomography. Reumatol Clin (Engl Ed). 2018, 14:309-10. 10.1016\/j.reuma.2017.01.017","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2024.02.003","article-title":"Radiotheranostics global market and future developments","author":"Al-Ibraheem A","year":"2024","unstructured":"Al-Ibraheem A, Zimmermann R, Abdlkadir AS, Herrmann K. Radiotheranostics global market and future developments. Semin Nucl Med. 2024, 10.1053\/j.semnuclmed.2024.02.003","journal-title":"Semin Nucl Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004213","article-title":"Intense 68Ga-FAPI uptake in a patient with myositis ossificans: mimicking bone malignancy","volume":"47","author":"Gong W","year":"2022","unstructured":"Gong W, Chen S, He L, Liu W, Zhang C. Intense 68Ga-FAPI uptake in a patient with myositis ossificans: mimicking bone malignancy. Clin Nucl Med. 2022, 47:638-9. 10.1097\/RLU.0000000000004213","journal-title":"Clin Nucl Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262096","article-title":"68Ga-FAPI as a diagnostic tool in sarcoma: data from the 68Ga-FAPI PET prospective observational trial","volume":"63","author":"Kessler L","year":"2022","unstructured":"Kessler L, Ferdinandus J, Hirmas N, et al.. 68Ga-FAPI as a diagnostic tool in sarcoma: data from the 68Ga-FAPI PET prospective observational trial. J Nucl Med. 2022, 63:89-95. 10.2967\/jnumed.121.262096","journal-title":"J Nucl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/245586-incidental-intense-fibroblast-activation-protein-inhibitor-fapi-uptake-in-bilateral-gluteal-myositis-ossificans-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T14:57:26Z","timestamp":1714661846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/245586-incidental-intense-fibroblast-activation-protein-inhibitor-fapi-uptake-in-bilateral-gluteal-myositis-ossificans-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.59520","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}